420 related articles for article (PubMed ID: 25375093)
21. Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail.
Kugelman JR; Kugelman-Tonos J; Ladner JT; Pettit J; Keeton CM; Nagle ER; Garcia KY; Froude JW; Kuehne AI; Kuhn JH; Bavari S; Zeitlin L; Dye JM; Olinger GG; Sanchez-Lockhart M; Palacios GF
Cell Rep; 2015 Sep; 12(12):2111-20. PubMed ID: 26365189
[TBL] [Abstract][Full Text] [Related]
22. Structural and molecular basis for Ebola virus neutralization by protective human antibodies.
Misasi J; Gilman MS; Kanekiyo M; Gui M; Cagigi A; Mulangu S; Corti D; Ledgerwood JE; Lanzavecchia A; Cunningham J; Muyembe-Tamfun JJ; Baxa U; Graham BS; Xiang Y; Sullivan NJ; McLellan JS
Science; 2016 Mar; 351(6279):1343-6. PubMed ID: 26917592
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection.
Davis CW; Jackson KJL; McElroy AK; Halfmann P; Huang J; Chennareddy C; Piper AE; Leung Y; Albariño CG; Crozier I; Ellebedy AH; Sidney J; Sette A; Yu T; Nielsen SCA; Goff AJ; Spiropoulou CF; Saphire EO; Cavet G; Kawaoka Y; Mehta AK; Glass PJ; Boyd SD; Ahmed R
Cell; 2019 May; 177(6):1566-1582.e17. PubMed ID: 31104840
[TBL] [Abstract][Full Text] [Related]
24. Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana.
Phoolcharoen W; Bhoo SH; Lai H; Ma J; Arntzen CJ; Chen Q; Mason HS
Plant Biotechnol J; 2011 Sep; 9(7):807-16. PubMed ID: 21281425
[TBL] [Abstract][Full Text] [Related]
25. Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection.
Wec AZ; Bornholdt ZA; He S; Herbert AS; Goodwin E; Wirchnianski AS; Gunn BM; Zhang Z; Zhu W; Liu G; Abelson DM; Moyer CL; Jangra RK; James RM; Bakken RR; Bohorova N; Bohorov O; Kim DH; Pauly MH; Velasco J; Bortz RH; Whaley KJ; Goldstein T; Anthony SJ; Alter G; Walker LM; Dye JM; Zeitlin L; Qiu X; Chandran K
Cell Host Microbe; 2019 Jan; 25(1):39-48.e5. PubMed ID: 30629917
[TBL] [Abstract][Full Text] [Related]
26. Expanding the watch list for potential Ebola virus antibody escape mutations.
Patel JS; Quates CJ; Johnson EL; Ytreberg FM
PLoS One; 2019; 14(3):e0211093. PubMed ID: 30897171
[TBL] [Abstract][Full Text] [Related]
27. Combinatorial peptide-based epitope mapping from Ebola virus DNA vaccines and infections reveals residue-level determinants of antibody binding.
Ripoll DR; Mitchell DAJ; Dupuy LC; Wallqvist A; Schmaljohn C; Chaudhury S
Hum Vaccin Immunother; 2017 Dec; 13(12):2953-2966. PubMed ID: 28922082
[TBL] [Abstract][Full Text] [Related]
28. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice.
Bengtsson KL; Song H; Stertman L; Liu Y; Flyer DC; Massare MJ; Xu RH; Zhou B; Lu H; Kwilas SA; Hahn TJ; Kpamegan E; Hooper J; Carrion R; Glenn G; Smith G
Vaccine; 2016 Apr; 34(16):1927-35. PubMed ID: 26921779
[TBL] [Abstract][Full Text] [Related]
29. Enhanced
Chabot S; Gimie Y; Obeid K; Kim J; Meseda CA; Konduru K; Kaplan G; Sheng Fowler L; Weir JP; Peden K; Major ME
J Virol; 2022 Sep; 96(18):e0116621. PubMed ID: 36069549
[TBL] [Abstract][Full Text] [Related]
30. Pan-ebolavirus protective therapy by two multifunctional human antibodies.
Gilchuk P; Murin CD; Cross RW; Ilinykh PA; Huang K; Kuzmina N; Borisevich V; Agans KN; Geisbert JB; Zost SJ; Nargi RS; Sutton RE; Suryadevara N; Bombardi RG; Carnahan RH; Bukreyev A; Geisbert TW; Ward AB; Crowe JE
Cell; 2021 Oct; 184(22):5593-5607.e18. PubMed ID: 34715022
[TBL] [Abstract][Full Text] [Related]
31. Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies.
Murin CD; Gilchuk P; Ilinykh PA; Huang K; Kuzmina N; Shen X; Bruhn JF; Bryan AL; Davidson E; Doranz BJ; Williamson LE; Copps J; Alkutkar T; Flyak AI; Bukreyev A; Crowe JE; Ward AB
Cell Rep; 2021 Apr; 35(2):108984. PubMed ID: 33852862
[TBL] [Abstract][Full Text] [Related]
32. Detection of Ebola virus envelope using monoclonal and polyclonal antibodies in ELISA, surface plasmon resonance and a quartz crystal microbalance immunosensor.
Yu JS; Liao HX; Gerdon AE; Huffman B; Scearce RM; McAdams M; Alam SM; Popernack PM; Sullivan NJ; Wright D; Cliffel DE; Nabel GJ; Haynes BF
J Virol Methods; 2006 Nov; 137(2):219-28. PubMed ID: 16857271
[TBL] [Abstract][Full Text] [Related]
33. Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus.
Mohan GS; Li W; Ye L; Compans RW; Yang C
PLoS Pathog; 2012; 8(12):e1003065. PubMed ID: 23271969
[TBL] [Abstract][Full Text] [Related]
34. Structure of an antibody in complex with its mucin domain linear epitope that is protective against Ebola virus.
Olal D; Kuehne AI; Bale S; Halfmann P; Hashiguchi T; Fusco ML; Lee JE; King LB; Kawaoka Y; Dye JM; Saphire EO
J Virol; 2012 Mar; 86(5):2809-16. PubMed ID: 22171276
[TBL] [Abstract][Full Text] [Related]
35. Construction and evaluation of DNA vaccine encoding Ebola virus glycoprotein fused with lysosome-associated membrane protein.
Liu Y; Sun B; Pan J; Feng Y; Ye W; Xu J; Lan M; Sun H; Zhang X; Sun Y; Yang S; Shi J; Zhang F; Cheng L; Jiang D; Yang K
Antiviral Res; 2021 Sep; 193():105141. PubMed ID: 34274417
[TBL] [Abstract][Full Text] [Related]
36. [Research progress on ebola virus glycoprotein].
Ding GY; Wang ZY; Gao L; Jiang BF
Bing Du Xue Bao; 2013 Mar; 29(2):233-7. PubMed ID: 23757858
[TBL] [Abstract][Full Text] [Related]
37. Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors.
Fan P; Chi X; Liu G; Zhang G; Chen Z; Liu Y; Fang T; Li J; Banadyga L; He S; Yu C; Qiu X; Chen W
MAbs; 2020; 12(1):1742457. PubMed ID: 32213108
[TBL] [Abstract][Full Text] [Related]
38. Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb.
Qiu X; Audet J; Wong G; Fernando L; Bello A; Pillet S; Alimonti JB; Kobinger GP
Sci Rep; 2013 Nov; 3():3365. PubMed ID: 24284388
[TBL] [Abstract][Full Text] [Related]
39. Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies.
Qiu X; Alimonti JB; Melito PL; Fernando L; Ströher U; Jones SM
Clin Immunol; 2011 Nov; 141(2):218-27. PubMed ID: 21925951
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal Human Antibody Repertoire against Complete Viral Proteome from Ebola Virus Survivor Reveals Protective Sites for Vaccine Design.
Khurana S; Ravichandran S; Hahn M; Coyle EM; Stonier SW; Zak SE; Kindrachuk J; Davey RT; Dye JM; Chertow DS
Cell Host Microbe; 2020 Feb; 27(2):262-276.e4. PubMed ID: 32053790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
